Verve Therapeutics
David Sinnott is the quality assurance auditor at Verve Therapeutics. He has over 21 years of experience in quality control and quality assurance, in the pharmaceutical and biotechnology industries. Prior to joining Verve, he was the senior manager of supplier quality/quality systems at Solid Biosciences. Mr. Sinnott received a B.S in chemistry, with minors in physics and mathematics, from Bridgewater State University and his M.S. in regulatory affairs for drug, biologics, and medical devices from Northeastern University. In addition, Mr. Sinnott has been certified as a quality auditor by the American Society for Quality.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.